Verdence Capital Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.81M | Buy |
|
|||||
|
2025
Q1 | $2.89M | Buy |
|
|||||
|
2024
Q4 | $2.13M | Buy |
|
|||||
|
2024
Q3 | $2.3M | Buy |
|
|||||
|
2024
Q2 | $2.14M | Buy |
|
|||||
|
2024
Q1 | $1.18M | Buy |
|
|||||
|
2023
Q4 | $1.11M | Sell |
|
|||||
|
2023
Q3 | $1.19M | Buy |
|
|||||
|
2023
Q2 | $1.18M | Sell |
|
|||||
|
2023
Q1 | $1.29M | Sell |
|
|||||
|
2022
Q4 | $1.27M | Buy |
|
|||||
|
2022
Q3 | $956K | Buy |
|
|||||
|
2022
Q2 | $1.1M | Buy |
|
|||||
|
2022
Q1 | $921K | Buy |
|
|||||
|
2021
Q4 | $803K | Buy |
|
|||||
|
2021
Q3 | $731K | Buy |
|
|||||
|
2021
Q2 | $619K | Sell |
|
|||||
|
2021
Q1 | $518K | Buy |
|
|||||
|
2020
Q4 | $307K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $561K | Sell |
|
|||||
|
2018
Q3 | $763K | Sell |
|
|||||
|
2018
Q2 | $1.14M | Sell |
|
|||||
|
2018
Q1 | $1.29M | Sell |
|
|||||
|
2017
Q4 | $1.34M | Buy |
|